|
HHS Social Determinants of Health Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
ACL, ACF, AHRQ, CDC, HRSA, IHS, OASH, FDA, CMS, SAMHSA
|
NIMHD, NIA, NICHD
|
The HHS SDoH Workgroup has developed a strategic vision to make health outcomes more equitable by improving the delivery of, and integration between healthcare and social services with a particular focus on individuals and populations in government health and human service programs at high risk for adverse outcomes. The SDoH workgroup identifies how HHS can address SDoH and work with other federal, state, local, tribal, and private sector partners to both ascertain and achieve shared objectives.
|
|
HHS Strategic Plan FY 2022-2026: Subcommittee for Objective 3.4
|
Committee, Work group, Advisory group, or Task Force
|
ASFR, CDC, ACF, SAMHSA, HRSA, ACL, ASPE
|
NICHD, NIMH
|
This subcommittee shares knowledge and expertise about HHS priorities and programs that will lead to the strategies at the heart of the HHS Strategic Plan Objective 3.4 to increase safeguards to empower families and communities to prevent and respond to neglect, abuse and violence, while supporting those who have experienced trauma or violence.
|
|
HHS Tick-Borne Diseases Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, OS
|
NIAID
|
The Tick-Borne Disease Working Group was established by Congress in 2016 as part of the 21st Century Cures Act to provide subject matter expertise and to review federal efforts related to all tick-borne diseases, to help ensure interagency coordination and minimize overlap, and to examine research priorities. The focus of this effort is the development of a report to the Secretary of Health and Human Services and Congress on the findings and any recommendations of the Working Group for the federal response to tick-borne disease prevention, treatment, and research, as well as how to address gaps in these areas.
|
|
HHS Tobacco Control Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, SAMHSA, OS
|
NIMHD, NCI, NIDA
|
The committee coordinates and initiates tobacco control activities across HHS agencies. The Committee meets monthly to promote information exchange and collaboration across HHS on a wide array of tobacco prevention and control issues, and to update members on the latest relevant research findings.
|
|
HHS Viral Hepatitis Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA, OASH, ONC
|
NIDDK, NIDA, OD/DPCPSI/OAR, NIAID
|
The Department of Health and Human Services (HHS) Viral Hepatitis Interagency Working Group was created by the Office of the Assistant Secretary for Health to address a report sponsored by the Institute of Medicine entitled Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The group meets to discuss collaborations and activities directed at achieving the goals for viral hepatitis research and control highlighted in the IOM report. (Although the National Institute of Allergy and Infectious Diseases (NIH Lead), the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Drug Abuse, and the NIH Office of AIDS Research represent the National Institutes of Health as Working Group members, other NIH Institutes/Centers/Offices also provide input to the VHIG through their participation in the Trans-NIH Committee on Viral Hepatitis.) The working group helped develop the 2021-2025 Viral Hepatitis National Strategic Plan.
|
|
HHS-Wide Stigma Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, IHS, SAMHSA
|
NIMH
|
Building on the momentum of the 2019 BMC Medicine Stigma Collection and the 2019 National Institute of Mental Health (NIMH) Global Mental Health Webinar, representatives from the National Institutes of Health (NIH) formed a Stigma Planning Workgroup to coordinate and chart a course forward for research related to stigma. The overall goal was to provide leadership, vision, and support to stigma research funded by the NIH. As the NIH-focused workgroup started to meet and gain traction, other Department of Health and Human Services (HHS) partners expressed interest in joining, including the Centers for Disease Control and Prevention (CDC), Health Resources and Services and Administration (HRSA), Indian Health Services (IHS), Food and Drug Administration (FDA), and Substance Abuse and Mental Health Services Administration (SAMHSA). Moving forward, this workgroup aims to promote cross-cutting stigma research and related activities and to enhance opportunities for knowledge transfer and collaborative learning in the field of stigma and discrimination research. To achieve this goal, the workgroup agrees to pursue several broad actions, including: (1) Clearly defining stigma and discrimination for the purpose of the workgroup; (2) Organizing a speaker's series to understand current stigma research findings, and interests within each federal agency; (3) Identifying and defining current stigma and discrimination research successes and challenges within each agency; (4) Identifying shared and individual priorities for each agency and how future activities could address identified challenges; (5) See enclosed list of HHS partner interests; (6) Advancing stigma and discrimination research training to build knowledge and skills among stigma-focused researchers and among other researchers seeking to increase capacity to conduct high-quality stigma and discrimination research; (7) Advancing the broader dissemination of stigma-related research; (8) Aligning technical assistance efforts to support one another; and (9) Supporting cross-cutting stigma and discrimination research as a field.
|
|
HHS/Office of the Secretary, Office of the Assistant Secretary for Planning and Evaluation (OS-ASPE) - Reentry/Criminal Justice Working |Group.
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, HRSA, SAMHSA
|
NHLBI, NIDA, NIMH
|
Through the Federal Interagency Reentry Council, federal agencies are working together to enhance community safety and well-being, assist those returning from prison and jail in becoming productive citizens, and save taxpayer dollars by lowering the direct and collateral costs of incarceration. Because reintegration to the community after incarceration intersects with issues of health, housing, education, employment, family, faith, and community well-being, the U.S Department of Health and Human Services (HHS) and other federal agencies are focusing on the reentry population with activities that aim to improve outcomes in these areas.
|
|
HIV/AIDS Cancer Match Study (HACM)
|
Research Initiative
|
CDC
|
NCI
|
A study linking HIV and cancer registries in multiple US regions to evaluate the spectrum of cancer risk in people living with HIV
|
|
Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings
|
Research Initiative
|
AHRQ
|
CC
|
The goal of the study is to provide rational, patient-defined, evidence-based recommendations to inform the redesign of the Medicare hospice benefit, transitioning policy from the current hospice benefit to a more patient-centered palliative care model.
|
|
Host Immune Responses to Antigens of Malaria Parasites
|
Research Initiative
|
FDA
|
OD/OIR, NIAID
|
Host Immune Responses to Antigens of Malaria Parasites
|